162 related articles for article (PubMed ID: 12097320)
1. Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factor-beta signaling by blocking the association of Smad proteins with Smad-binding element.
Lee DK; Kim BC; Brady JN; Jeang KT; Kim SJ
J Biol Chem; 2002 Sep; 277(37):33766-75. PubMed ID: 12097320
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.
Mori N; Morishita M; Tsukazaki T; Giam CZ; Kumatori A; Tanaka Y; Yamamoto N
Blood; 2001 Apr; 97(7):2137-44. PubMed ID: 11264182
[TBL] [Abstract][Full Text] [Related]
3. Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis.
Arnulf B; Villemain A; Nicot C; Mordelet E; Charneau P; Kersual J; Zermati Y; Mauviel A; Bazarbachi A; Hermine O
Blood; 2002 Dec; 100(12):4129-38. PubMed ID: 12393612
[TBL] [Abstract][Full Text] [Related]
4. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
6. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
[TBL] [Abstract][Full Text] [Related]
7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
8. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.
Pardali K; Kurisaki A; Morén A; ten Dijke P; Kardassis D; Moustakas A
J Biol Chem; 2000 Sep; 275(38):29244-56. PubMed ID: 10878024
[TBL] [Abstract][Full Text] [Related]
9. Repression of Smad2 and Smad3 transactivating activity by association with a novel splice variant of CCAAT-binding factor C subunit.
Chen F; Ogawa K; Liu X; Stringfield TM; Chen Y
Biochem J; 2002 Jun; 364(Pt 2):571-7. PubMed ID: 12023901
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein.
Shen X; Hu PP; Liberati NT; Datto MB; Frederick JP; Wang XF
Mol Biol Cell; 1998 Dec; 9(12):3309-19. PubMed ID: 9843571
[TBL] [Abstract][Full Text] [Related]
11. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
Nagarajan RP; Liu J; Chen Y
J Biol Chem; 1999 Oct; 274(44):31229-35. PubMed ID: 10531318
[TBL] [Abstract][Full Text] [Related]
12. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
Mori N; Morishita M; Tsukazaki T; Yamamoto N
Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
[TBL] [Abstract][Full Text] [Related]
14. The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor beta signaling through interaction with CREB-binding protein.
Tomita M; Choe J; Tsukazaki T; Mori N
Oncogene; 2004 Oct; 23(50):8272-81. PubMed ID: 15467747
[TBL] [Abstract][Full Text] [Related]
15. Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability.
Williams TM; Williams ME; Heaton JH; Gelehrter TD; Innis JW
Nucleic Acids Res; 2005; 33(14):4475-84. PubMed ID: 16087734
[TBL] [Abstract][Full Text] [Related]
16. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.
Akiyoshi S; Inoue H; Hanai J; Kusanagi K; Nemoto N; Miyazono K; Kawabata M
J Biol Chem; 1999 Dec; 274(49):35269-77. PubMed ID: 10575014
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
18. Linking Smads and transcriptional activation.
Inman GJ
Biochem J; 2005 Feb; 386(Pt 1):e1-e3. PubMed ID: 15702493
[TBL] [Abstract][Full Text] [Related]
19. Distinct oligomeric states of SMAD proteins in the transforming growth factor-beta pathway.
Jayaraman L; Massague J
J Biol Chem; 2000 Dec; 275(52):40710-7. PubMed ID: 11018029
[TBL] [Abstract][Full Text] [Related]
20. The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
Forlani G; Abdallah R; Accolla RS; Tosi G
J Virol; 2016 Jan; 90(7):3708-21. PubMed ID: 26792751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
